Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT03678558
NCT03678558CompletedNot Applicable

Cytochalasin B for Oocyte Vitrification

Ibn Sina Hospital1 site in 1 country612 target enrollmentStarted: September 25, 2018Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
612
Locations
1
Primary Endpoint
survival after thawing
Study OverviewStudy DesignEligibility CriteriaArms & InterventionsOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

Using the cytoskeleton Stabilizer the Cytochalasin B would improve the outcome of oocyte vitrification.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Other
Masking
Triple (Participant, Care Provider, Investigator)

Eligibility Criteria

Ages
18 Years to 42 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •indication for oocyte vitrification

Exclusion Criteria

  • Not provided

Arms & Interventions

Cytochalasin B supplemented vitrification medium

Experimental

Intervention: Cytochalasin B supplemented vitrification medium (Other)

Vitrification medium with no supplementation

No Intervention

Outcomes

Primary Outcomes

survival after thawing

Time Frame: 6 days of culture

Secondary Outcomes

  • ongoing pregnancy rate(12 months)
  • fertilization rate(6 days of culture)
  • clinical pregnancy rate(three months)
  • Rates of blastocyst formation and quality(6 days of culture)
  • embryo utilisation rate(6 days of culture)

Investigators

Sponsor Class
Other Gov
Responsible Party
Principal Investigator
Principal Investigator

Muhammad Fawzy

IVF Lab Director

Ibn Sina Hospital

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Oocyte Vitrification Aided With Latrunculin AInfertility
NCT03678571Ibn Sina Hospital400
Completed
Not Applicable
Oocyte Vitrification for In Vitro Fertilization (IVF) Patients and Women With Fertility Threatening ConditionsFertility Preservation
NCT01448460University of Louisville8
Recruiting
Not Applicable
Vitrification of Oocytes Matured by CAPA-IVMFertility Preservation
NCT06157619Centro de Fertilidad y Reproducción Asistida, Peru20
Completed
Unknown
Investigation of methods to prevent oocyte degeneration in minimally invasive ICSIone
JPRN-UMIN000050410Kusuhara Women's Clinic170
Completed
Early Phase 1
Effect of Oocyte Vitrification on Fertilization Rate, Embryo Quality and DevelopmentFertility
NCT01422395Main Line Fertility Center40